This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

India's CCI clears drugmakers, trade groups in 14-year pharma antitrust case

By Freny Patel ( June 30, 2026, 01:37 GMT | Insight) -- Pharmaceutical companies including Dr Reddy's, Cipla, Sun Pharma and GSK, along with chemists' associations, have been cleared of coordinated restrictive distribution practices by the Competition Commission of India, which closed a 14-year-old antitrust case after finding insufficient evidence.Leading pharmaceutical manufacturers including Cipla, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Pfizer, GlaxoSmithKline Pharmaceuticals and Torrent Pharmaceuticals have been cleared of long-running antitrust allegations after India's competition watchdog closed a 14-year-old case challenging pharmaceutical distribution practices....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login